Search results
Author(s):
Kenan Yalta
,
Mustafa Yılmaztepe
,
Cafer Zorkun
Added:
3 years ago
In the past decades, takotsubo cardiomyopathy (TTC) has emerged as a specific form of acute and transient myocardial disease, predominantly affecting postmenopausal women in the clinical setting.1–4 In general, myocardial involvement in this setting appears to harbour a regional pattern particularly extending beyond the territory of a single coronary artery (and usually without concomitant…
View more
Foreword
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
3 years ago
Article
Author(s):
Martin Nicol
,
Mathilde Baudet
,
Alain Cohen-Solal
Added:
3 years ago
Advances in the early detection and treatment of cancer have improved overall survival in cancer patients. Nevertheless, cardiovascular diseases appear as the major cause of morbidity and mortality among cancer survivors.1 Left ventricular (LV) dysfunction and/or heart failure are the most common cardiovascular complications after administration of chemotherapies. The term ‘cardiotoxicity’ is…
View more
Author(s):
Erez Marcusohn
,
Ofer Kobo
,
Maria Postnikov
,
et al
Added:
2 years ago
Author(s):
Sriram D Rao
,
Srinath Adusumalli
,
Jeremy A Mazurek
Added:
3 years ago
Heart failure (HF) remains one of the most common medical conditions worldwide, placing a continuously growing burden on healthcare providers. Within the HF population itself, the subset of patients who develop pulmonary hypertension (PH-LHD) has been identified as having a significantly higher morbidity and mortality.1 There are limited therapeutic options for PH-LHD and it often complicates the…
View more
Author(s):
Jackson J Liang
,
David J Callans
Added:
3 years ago
As the population ages, the incidence of both AF and heart failure (HF) will continue to increase. By the year 2030, there will be an estimated >12 million patients with AF and >8 million patients with HF.1,2 A significant proportion of patients with HF have reduced (<50%) left ventricular ejection fraction (heart failure with reduced ejection fraction, HFrEF) and the coexistance of AF…
View more
Author(s):
Alberto Aimo
,
Giosafat Spitaleri
,
Dario Nieri
,
et al
Added:
1 year ago
SGLT2 Inhibitors in HFpEF
Author(s):
Brent Deschaine
,
Sahil Verma
,
Hussein Rayatzadeh
Added:
1 year ago
Article
Author(s):
Anupam A Kumar
,
Lena E Tran
,
Aniket S Rali
,
et al
Added:
1 year ago
Author(s):
Mattia Arrigo
,
Petra Nijst
,
Alain Rudiger
Added:
3 years ago
Heart failure is a clinical syndrome induced by cardiac abnormalities resulting in reduced cardiac output and/or elevated intra-cardiac end-diastolic pressures and causing symptoms that are often accompanied by typical physical signs.1 Demographic changes, improved treatment of several acute cardiac disorders, such myocardial infarction, arrhythmia and congenital heart disease, and increased long…
View more